Clozapine for Cannabis Use in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
SchizophreniaCannabis AbuseCannabis DependenceDual Diagnosis
Interventions
DRUG

Clozapine

Clozapine: target dose of 400mg per day with a maximum dose of 550mg per day

DRUG

Risperidone

Clozapine: target dose of 4mg per day with a maximum dose of 6mg per day

Trial Locations (9)

27610

University of North Carolina/UNC Center for Excellence in Community Mental Health, Raleigh

29203

University of South Carolina, Columbia

33136

University of Miami, Miami

49503

Michigan State University / Cherry Street Health Services, Grand Rapids

92845

CNS Network Inc, Garden Grove

94607

Pacific Research Partners, Oakland

01605

Unversity of Massachusetts Medical School, Worcester

03756

Dartmouth Hitchcock Medical Center, Lebanon

05701

Rutland Regional Medical Center, Rutland

All Listed Sponsors
collaborator

University of South Carolina

OTHER

collaborator

Michigan State University

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Massachusetts, Worcester

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01639872 - Clozapine for Cannabis Use in Schizophrenia | Biotech Hunter | Biotech Hunter